Skip to Main Content

WASHINGTON — Representatives from the drug industry’s top lobbying group will head to the White House Tuesday morning for a rendezvous with President Trump.

Steve Ubl, president and CEO of the Pharmaceutical Research and Manufacturers of America, and several of PhRMA’s board members will meet with Trump and Vice President Mike Pence at 9 a.m. in the Oval Office.


The meeting follows Trump’s incendiary comments about drug makers before and after his election. In a recent press conference, he accused the industry of “getting away with murder” and pledged to change the way the federal government pays for prescription drugs.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Comments are closed.